Cancer stem cells: Culprits in endocrine resistance and racial disparities in breast cancer outcomes
出版年份 2020 全文链接
标题
Cancer stem cells: Culprits in endocrine resistance and racial disparities in breast cancer outcomes
作者
关键词
Breast cancer, Stem cells, Endocrine resistance, Endocrine therapy, Disparities
出版物
CANCER LETTERS
Volume 500, Issue -, Pages 64-74
出版商
Elsevier BV
发表日期
2020-12-09
DOI
10.1016/j.canlet.2020.12.014
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Racial Differences in the Association Between Luminal Master Regulator Gene Expression Levels and Breast Cancer Survival
- (2020) Jung S. Byun et al. CLINICAL CANCER RESEARCH
- Racial differences in estrogen receptor staining levels and implications for treatment and survival among estrogen receptor positive, HER2-negative invasive breast cancers
- (2020) Kristen S. Purrington et al. BREAST CANCER RESEARCH AND TREATMENT
- Eicosanoids in Cancer: Prostaglandin E2 Receptor 4 in Cancer Therapeutics and Immunotherapy
- (2020) Mc Millan Ching et al. Frontiers in Pharmacology
- Loss of aryl hydrocarbon receptor potentiates FoxM1 signaling to enhance self‐renewal of colonic stem and progenitor cells
- (2020) Huajun Han et al. EMBO JOURNAL
- p53 destabilizing protein skews asymmetric division and enhances NOTCH activation to direct self-renewal of TICs
- (2020) Hye Yeon Choi et al. Nature Communications
- Notch Signaling Pathway and Endocrine Resistance in Breast Cancer
- (2020) Jing-Wen Bai et al. Frontiers in Pharmacology
- Cancer stem-like properties of hormonal therapy-resistant breast cancer cells
- (2019) Kanami Uchiumi et al. Breast Cancer
- CDK4/6 Inhibitors Expand the Therapeutic Options in Breast Cancer: Palbociclib, Ribociclib and Abemaciclib
- (2019) Tanja K. Eggersmann et al. BIODRUGS
- Advances in inhibition of protein-protein interactions targeting hypoxia-inducible factor-1 for cancer therapy
- (2019) Jia Li et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Activation of the hypoxia pathway in breast cancer tissue and patient survival are inversely associated with tumor ascorbate levels
- (2019) Elizabeth J. Campbell et al. BMC CANCER
- A multiple breast cancer stem cell model to predict recurrence of T1–3, N0 breast cancer
- (2019) Yan Qiu et al. BMC CANCER
- The NF-KB pathway and endocrine therapy resistance in breast cancer
- (2019) Phungern Khongthong et al. ENDOCRINE-RELATED CANCER
- DAXX Suppresses Tumor-Initiating Cells in Estrogen Receptor–Positive Breast Cancer Following Endocrine Therapy
- (2019) Daniel S. Peiffer et al. CANCER RESEARCH
- Palbociclib as single agent or in combination with the endocrine therapy received before disease progression for estrogen receptor-positive, HER2-negative metastatic breast cancer: TREnd trial
- (2018) L Malorni et al. ANNALS OF ONCOLOGY
- HIF1-alpha expressing cells induce a hypoxic-like response in neighbouring cancer cells
- (2018) Hannah Harrison et al. BMC CANCER
- Antiestrogen Therapy Increases Plasticity and Cancer Stemness of Prolactin-Induced ERα+Mammary Carcinomas
- (2018) Michael P. Shea et al. CANCER RESEARCH
- ZMYND8 acetylation mediates HIF-dependent breast cancer progression and metastasis
- (2018) Yan Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- Buparlisib plus fulvestrant in postmenopausal women with hormone-receptor-positive, HER2-negative, advanced breast cancer progressing on or after mTOR inhibition (BELLE-3): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2018) Angelo Di Leo et al. LANCET ONCOLOGY
- Intermittent hypoxia induces a metastatic phenotype in breast cancer
- (2018) Anna Chen et al. ONCOGENE
- Endocrine Therapy in Premenopausal Hormone Receptor Positive/Human Epidermal Growth Receptor 2 Negative Metastatic Breast Cancer: Between Guidelines and Literature
- (2018) Richard Tancredi et al. ONCOLOGIST
- First-in-human study of LY3039478, an oral Notch signaling inhibitor in advanced or metastatic cancer
- (2018) C Massard et al. ANNALS OF ONCOLOGY
- CDK4/6 inhibitors in advanced hormone receptor-positive/HER2-negative breast cancer: a systematic review and meta-analysis of randomized trials
- (2018) Carlo Messina et al. BREAST CANCER RESEARCH AND TREATMENT
- AhR ligand aminoflavone suppresses α6-integrin-Src-Akt signaling to attenuate tamoxifen resistance in breast cancer cells
- (2018) Petreena S. Campbell et al. JOURNAL OF CELLULAR PHYSIOLOGY
- C/EBPδ links IL-6 and HIF-1 signaling to promote breast cancer stem cell-associated phenotypes
- (2018) Kuppusamy Balamurugan et al. ONCOGENE
- Fulvestrant-Based Combination Therapy for Second-Line Treatment of Hormone Receptor-Positive Advanced Breast Cancer
- (2018) Sarah Sammons et al. Targeted Oncology
- The genetic landscape and clonal evolution of breast cancer resistance to palbociclib plus fulvestrant in the PALOMA-3 trial
- (2018) Ben O'Leary et al. Cancer Discovery
- Racial differences in long-term adjuvant endocrine therapy adherence and mortality among Medicaid-insured breast cancer patients in Texas: Findings from TCR-Medicaid linked data
- (2018) Albert J. Farias et al. BMC CANCER
- A phase 1 dose escalation and expansion study of Tarextumab (OMP-59R5) in patients with solid tumors
- (2018) David C. Smith et al. INVESTIGATIONAL NEW DRUGS
- Vandetanib (ZD6474) induces antiangiogenesis through mTOR–HIF-1 alpha–VEGF signaling axis in breast cancer cells
- (2018) Ling Li et al. OncoTargets and Therapy
- CD49f Can Act as a Biomarker for Local or Distant Recurrence in Breast Cancer
- (2017) Feng Ye et al. Journal of Breast Cancer
- Racial Differences in PAM50 Subtypes in the Carolina Breast Cancer Study
- (2017) Melissa A. Troester et al. JNCI-Journal of the National Cancer Institute
- Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation
- (2017) Abdullah Al-Dhfyan et al. Molecular Cancer
- 20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years
- (2017) Hongchao Pan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Myc mediates cancer stem-like cells and EMT changes in triple negative breast cancers cells
- (2017) Shuping Yin et al. PLoS One
- Integrin-β4 identifies cancer stem cell-enriched populations of partially mesenchymal carcinoma cells
- (2017) Brian Bierie et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Role of Integrin α6 (CD49f) in Stem Cells: More than a Conserved Biomarker
- (2017) Paul H. Krebsbach et al. STEM CELLS AND DEVELOPMENT
- Discovery of naturally occurring ESR1 mutations in breast cancer cell lines modelling endocrine resistance
- (2017) Lesley-Ann Martin et al. Nature Communications
- EGFR signaling promotes inflammation and cancer stem-like activity in inflammatory breast cancer
- (2017) Xiaoping Wang et al. Oncotarget
- Laminin Modulates the Stem Cell Population in LM05-E Murine Breast Cancer Cells through the Activation of the MAPK/ERK Pathway
- (2017) Damián E. Berardi et al. Cancer Research and Treatment
- Racial Differences in PAM50 Subtypes in the Carolina Breast Cancer Study
- (2017) Melissa A. Troester et al. JNCI-Journal of the National Cancer Institute
- Comparison of Breast Cancer Molecular Features and Survival by African and European Ancestry in The Cancer Genome Atlas
- (2017) Dezheng Huo et al. JAMA Oncology
- AhR ligand Aminoflavone inhibits α6-integrin expression and breast cancer sphere-initiating capacity
- (2016) Eileen Brantley et al. CANCER LETTERS
- PHGDH Expression Is Required for Mitochondrial Redox Homeostasis, Breast Cancer Stem Cell Maintenance, and Lung Metastasis
- (2016) D. Samanta et al. CANCER RESEARCH
- FOXA1 expression affects the proliferation activity of luminal breast cancer stem cell populations
- (2016) Kana Tachi et al. CANCER SCIENCE
- Genetic variations in the Hippo signaling pathway and breast cancer risk in African American women in the AMBER Consortium
- (2016) Jianmin Zhang et al. CARCINOGENESIS
- Identification of Domains for Efficient Notch Signaling Activity in Immobilized Notch Ligand Proteins
- (2016) Ledi Liu et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial
- (2016) Massimo Cristofanilli et al. LANCET ONCOLOGY
- Hypoxia regulates stemness of breast cancer MDA-MB-231 cells
- (2016) Jing Xie et al. MEDICAL ONCOLOGY
- ITGA6 is directly regulated by hypoxia-inducible factors and enriches for cancer stem cell activity and invasion in metastatic breast cancer models
- (2016) Danielle L. Peacock Brooks et al. Molecular Cancer
- Addiction to the IGF2-ID1-IGF2 circuit for maintenance of the breast cancer stem-like cells
- (2016) K Tominaga et al. ONCOGENE
- COX-2 Induces Breast Cancer Stem Cells via EP4/PI3K/AKT/NOTCH/WNT Axis
- (2016) Mousumi Majumder et al. STEM CELLS
- Self-renewal of CD133hi cells by IL6/Notch3 signalling regulates endocrine resistance in metastatic breast cancer
- (2016) Pasquale Sansone et al. Nature Communications
- CDK4 regulates cancer stemness and is a novel therapeutic target for triple-negative breast cancer
- (2016) Meiou Dai et al. Scientific Reports
- Aurora kinase B is important for antiestrogen resistant cell growth and a potential biomarker for tamoxifen resistant breast cancer
- (2015) Sarah L Larsen et al. BMC CANCER
- Race-associated biological differences among Luminal A breast tumors
- (2015) Monica D’Arcy et al. BREAST CANCER RESEARCH AND TREATMENT
- Race, response to chemotherapy, and outcome within clinical breast cancer subtypes
- (2015) J. R. Tichy et al. BREAST CANCER RESEARCH AND TREATMENT
- Factors Promoting Tamoxifen Resistance in Breast Cancer via Stimulating Breast Cancer Stem Cell Expansion
- (2015) Diane Ojo et al. CURRENT MEDICINAL CHEMISTRY
- Notch promotes recurrence of dormant tumor cells following HER2/neu-targeted therapy
- (2015) Daniel L. Abravanel et al. JOURNAL OF CLINICAL INVESTIGATION
- Ethnicity-Dependent and -Independent Heterogeneity in Healthy Normal Breast Hierarchy Impacts Tumor Characterization
- (2015) Harikrishna Nakshatri et al. Scientific Reports
- Anti-estrogen Resistance in Human Breast Tumors Is Driven by JAG1-NOTCH4-Dependent Cancer Stem Cell Activity
- (2015) Bruno M. Simões et al. Cell Reports
- Racial disparities in initiation of adjuvant endocrine therapy of early breast cancer
- (2014) Katherine E. Reeder-Hayes et al. BREAST CANCER RESEARCH AND TREATMENT
- ER-α variant ER-α36 mediates antiestrogen resistance in ER-positive breast cancer stem/progenitor cells
- (2014) Hao Deng et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Regulated Splicing of the α6 Integrin Cytoplasmic Domain Determines the Fate of Breast Cancer Stem Cells
- (2014) Hira Lal Goel et al. Cell Reports
- Breast Cancer Subtypes and Previously Established Genetic Risk Factors: A Bayesian Approach
- (2013) K. M. O'Brien et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Preclinical and Clinical Studies of Gamma Secretase Inhibitors with Docetaxel on Human Breast Tumors
- (2013) A. F. Schott et al. CLINICAL CANCER RESEARCH
- MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosis
- (2013) Atsushi Terunuma et al. JOURNAL OF CLINICAL INVESTIGATION
- BRCA1 is a key regulator of breast differentiation through activation of Notch signalling with implications for anti-endocrine treatment of breast cancers
- (2013) N. E. Buckley et al. NUCLEIC ACIDS RESEARCH
- Evaluation of the expression of stem cell markers in human breast cancer reveals a correlation with clinical progression and metastatic disease in ductal carcinoma
- (2013) TRACEY AMANDA MARTIN et al. ONCOLOGY REPORTS
- Triple Negative Breast Tumors in African-American and Hispanic/Latina Women Are High in CD44+, Low in CD24+, and Have Loss of PTEN
- (2013) Yanyuan Wu et al. PLoS One
- Differentially Expressed Transcripts and Dysregulated Signaling Pathways and Networks in African American Breast Cancer
- (2013) Paul A. Stewart et al. PLoS One
- Crosstalk between PKCα and Notch-4 in endocrine-resistant breast cancer cells
- (2013) J Yun et al. Oncogenesis
- Vandetanib for the Treatment of Symptomatic or Progressive Medullary Thyroid Cancer in Patients with Unresectable Locally Advanced or Metastatic Disease: U.S. Food and Drug Administration Drug Approval Summary
- (2012) K. Thornton et al. CLINICAL CANCER RESEARCH
- P-Cadherin Is Coexpressed with CD44 and CD49f and Mediates Stem Cell Properties in Basal-like Breast Cancer
- (2012) André Filipe Vieira et al. STEM CELLS
- The tumor microenvironment modulates tamoxifen resistance in breast cancer: a role for soluble stromal factors and fibronectin through β1 integrin
- (2011) Osvaldo Pontiggia et al. BREAST CANCER RESEARCH AND TREATMENT
- Activation of the aryl hydrocarbon receptor represses mammosphere formation in MCF-7 cells
- (2011) Shuai Zhao et al. CANCER LETTERS
- Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer
- (2011) José Baselga et al. NEW ENGLAND JOURNAL OF MEDICINE
- Maintenance of hormone responsiveness in luminal breast cancers by suppression of Notch
- (2011) J. M. Haughian et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Aminoflavone, a Ligand of the Aryl Hydrocarbon Receptor, Inhibits HIF-1 Expression in an AhR-Independent Fashion
- (2010) E. Terzuoli et al. CANCER RESEARCH
- Regulation of Breast Cancer Stem Cell Activity by Signaling through the Notch4 Receptor
- (2010) H. Harrison et al. CANCER RESEARCH
- Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial
- (2010) Jack Cuzick et al. LANCET ONCOLOGY
- Cyclin D1 is a direct target of JAG1-mediated Notch signaling in breast cancer
- (2009) Brenda Cohen et al. BREAST CANCER RESEARCH AND TREATMENT
- The Canonical Notch Signaling Pathway: Unfolding the Activation Mechanism
- (2009) Raphael Kopan et al. CELL
- Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
- (2009) Maggie C. U. Cheang et al. JNCI-Journal of the National Cancer Institute
- Cooperation of Notch and Ras/MAPK signaling pathways in human breast carcinogenesis
- (2009) Suruchi Mittal et al. Molecular Cancer
- Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1α
- (2009) A Soeda et al. ONCOGENE
- NUMB controls p53 tumour suppressor activity
- (2008) Ivan N. Colaluca et al. NATURE
- β1 Integrin deletion from the basal compartment of the mammary epithelium affects stem cells
- (2008) Ilaria Taddei et al. NATURE CELL BIOLOGY
- Induction of ErbB-3 Expression by α6β4 Integrin Contributes to Tamoxifen Resistance in ERβ1-Negative Breast Carcinomas
- (2008) Valentina Folgiero et al. PLoS One
- Differential effects of selective oestrogen receptor modulators (SERMs) tamoxifen, ospemifene and raloxifene on human osteoclasts in vitro
- (2007) H Michael et al. BRITISH JOURNAL OF PHARMACOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started